What is LOPJLB’s current signal on CLLS?

LOPJLB’s latest quantitative signal on Cellectis S.A. (CLLS) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CLLS in?

Cellectis S.A. (CLLS) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Cellectis S.A. (CLLS) do?

Cellectis S.A. is a biotechnology firm in the clinical development stage, concentrating on the creation of immuno-oncology therapies. These therapies harness gene-edited T-cells engineered to express chimeric antigen receptors, designed to specifically identify and eliminate malignant cells. Its operations are divided into two distinct divisions: Therapeutics and Plants. The therapeutic pipelin…

Where is Cellectis S.A. based / listed?

Cellectis S.A. is based in FR, listed on NASDAQ.

Cellectis S.A. (CLLS)

COMPARE

Healthcare · Biotechnology · NASDAQ · FR

$1.25-6.72%Close

SELLCRISIS · day 19

[SCORES & PROFILE]

FUND: 0
VALUE: 1
GROWTH: 30
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-56.5%

REV YoY-

ROE-94.1%

EPS YoY-

ROA-24.4%

GROSS

-108

NET

-115

[VALUATION]

P/E TTM-2.15

P/E FWD-

SECTOR PE20.12

INDUSTRY PE13.79

P/B3.44

P/FCF-

EV/EBITDA-3.45

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E205.94

ALTMAN Z-

CURR RATIO1.37

ND/EBITDA-

BETA3.00

Cellectis S.A. (CLLS)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news